NEWS + MEDIA
> Press Releases   > Archive > Presentations    and Publications > Calendar    of Events > Media    Coverage Press Releases Archive 12/10/2012 Senesco Provides Summary of SNS01-T Progress in Phase 1b/2a Trial Interim Results presented at ASH 11/28/2012 Senesco to Present on SNS01-T at 54th American Society of Hematology Annual Meeting 11/26/2012 Senesco Technologies Provides Corporate Update 11/21/2012 Senesco Announces Quotation of Common Stock on the Over-the-Counter Securities Market 11/19/2012 Senesco Announces Delisting of Common Stock from NYSE MKT LLC and Pending Transfer to an Over-the-Counter Securities Market 11/15/2012 Senesco Technologies Reports First Quarter Fiscal 2013 Financial Results 11/7/2012 Senesco Announces Expansion of Phase 1b/2a Study to Include Diffuse Large B-Cell Lymphoma and Mantle Cell Lymphoma First DLBCL Patient Dosed in Study 9/18/2012 Senesco Technologies Reports Fiscal Year 2012 Financial Results 9/18/2012 Senesco Technologies Reports Fiscal Year 2012 Financial Results 9/13/2012 Senesco Announces First Dose of SNS01-T in Cohort 2 of Phase 1b/2a Study in Multiple Myeloma Trial Next Page

Disclaimer